FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056544932> ?p ?o ?g. }

• W2056544932 endingPage "163" @default.
• W2056544932 startingPage "157" @default.
• W2056544932 abstract "Objective Fludarabine, cyclophosphamide and rituximab (FCR) therapy for lymphoid malignancies has historically been associated with a low reported incidence of Pneumocystis jirovecii pneumonia (PJP). However, prophylaxis was routinely used in early studies, and molecular diagnostic tools were not employed. The objective of this study was to review the incidence of PJP during and post-FCR in the era of highly sensitive molecular diagnostics and 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)–computerised tomography (CT). Methods All patients treated with standard FCR at the Peter MacCallum Cancer Centre (March 2009 to June 2012) were identified from a medications management database. Laboratory-confirmed PJP cases during this time were identified from an electronic database. Results Overall, 66 patients were treated with a median of 5.5 FCR cycles. Eight PJP cases were identified, 6 of whom had received chemotherapy prior to FCR. In 5 cases, 18F-FDG PET demonstrated bilateral ground-glass infiltrates. Median CD4+ lymphocyte counts at time of PJP diagnosis and 9–12 months following FCR were 123 and 400 cells/μL, respectively. In patients receiving no prophylaxis, 9.1% developed PJP during FCR. The rate following FCR was 18.4%, with median onset at 6 months (2.4–24 months). Conclusion Given the high rate of late-onset PJP, consideration should be given for extended PJP prophylaxis for up to 12 months post-FCR, particularly in pretreated patients. Further evaluation of the role of CD4+ monitoring is warranted to quantify risk of disease development and to guide duration of prophylaxis." @default.
• W2056544932 created "2016-06-24" @default.
• W2056544932 creator A5028760783 @default.
• W2056544932 creator A5034517642 @default.
• W2056544932 creator A5048604619 @default.
• W2056544932 creator A5050718813 @default.
• W2056544932 creator A5059566329 @default.
• W2056544932 creator A5067655143 @default.
• W2056544932 creator A5069678589 @default.
• W2056544932 creator A5081326206 @default.
• W2056544932 date "2013-06-15" @default.
• W2056544932 modified "2023-09-28" @default.
• W2056544932 title "Late-onsetPneumocystis jiroveciipneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxis" @default.
• W2056544932 cites W1842513321 @default.
• W2056544932 cites W1872584362 @default.
• W2056544932 cites W1966676810 @default.
• W2056544932 cites W1997571024 @default.
• W2056544932 cites W2001850157 @default.
• W2056544932 cites W2003835506 @default.
• W2056544932 cites W2008003134 @default.
• W2056544932 cites W2014713514 @default.
• W2056544932 cites W2016735282 @default.
• W2056544932 cites W2059914770 @default.
• W2056544932 cites W2066371170 @default.
• W2056544932 cites W2069617608 @default.
• W2056544932 cites W2070799206 @default.
• W2056544932 cites W2078820016 @default.
• W2056544932 cites W2084366804 @default.
• W2056544932 cites W2091792486 @default.
• W2056544932 cites W2093599031 @default.
• W2056544932 cites W2095570712 @default.
• W2056544932 cites W2115225413 @default.
• W2056544932 cites W2119962983 @default.
• W2056544932 cites W2124791110 @default.
• W2056544932 cites W2125134816 @default.
• W2056544932 cites W2136616064 @default.
• W2056544932 cites W2140606816 @default.
• W2056544932 cites W2151177887 @default.
• W2056544932 cites W2155954788 @default.
• W2056544932 cites W2319623531 @default.
• W2056544932 cites W2324816636 @default.
• W2056544932 doi "https://doi.org/10.1111/ejh.12135" @default.
• W2056544932 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7163499" @default.
• W2056544932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23668894" @default.
• W2056544932 hasPublicationYear "2013" @default.
• W2056544932 type Work @default.
• W2056544932 sameAs 2056544932 @default.
• W2056544932 citedByCount "22" @default.
• W2056544932 countsByYear W20565449322013 @default.
• W2056544932 countsByYear W20565449322014 @default.
• W2056544932 countsByYear W20565449322015 @default.
• W2056544932 countsByYear W20565449322016 @default.
• W2056544932 countsByYear W20565449322017 @default.
• W2056544932 countsByYear W20565449322018 @default.
• W2056544932 countsByYear W20565449322020 @default.
• W2056544932 countsByYear W20565449322022 @default.
• W2056544932 crossrefType "journal-article" @default.
• W2056544932 hasAuthorship W2056544932A5028760783 @default.
• W2056544932 hasAuthorship W2056544932A5034517642 @default.
• W2056544932 hasAuthorship W2056544932A5048604619 @default.
• W2056544932 hasAuthorship W2056544932A5050718813 @default.
• W2056544932 hasAuthorship W2056544932A5059566329 @default.
• W2056544932 hasAuthorship W2056544932A5067655143 @default.
• W2056544932 hasAuthorship W2056544932A5069678589 @default.
• W2056544932 hasAuthorship W2056544932A5081326206 @default.
• W2056544932 hasBestOaLocation W20565449321 @default.
• W2056544932 hasConcept C120665830 @default.
• W2056544932 hasConcept C121332964 @default.
• W2056544932 hasConcept C126322002 @default.
• W2056544932 hasConcept C126838900 @default.
• W2056544932 hasConcept C141071460 @default.
• W2056544932 hasConcept C2776694085 @default.
• W2056544932 hasConcept C2776755627 @default.
• W2056544932 hasConcept C2778602436 @default.
• W2056544932 hasConcept C2779263901 @default.
• W2056544932 hasConcept C2779338263 @default.
• W2056544932 hasConcept C2780653079 @default.
• W2056544932 hasConcept C501593827 @default.
• W2056544932 hasConcept C61511704 @default.
• W2056544932 hasConcept C71924100 @default.
• W2056544932 hasConcept C86803240 @default.
• W2056544932 hasConcept C89423630 @default.
• W2056544932 hasConceptScore W2056544932C120665830 @default.
• W2056544932 hasConceptScore W2056544932C121332964 @default.
• W2056544932 hasConceptScore W2056544932C126322002 @default.
• W2056544932 hasConceptScore W2056544932C126838900 @default.
• W2056544932 hasConceptScore W2056544932C141071460 @default.
• W2056544932 hasConceptScore W2056544932C2776694085 @default.
• W2056544932 hasConceptScore W2056544932C2776755627 @default.
• W2056544932 hasConceptScore W2056544932C2778602436 @default.
• W2056544932 hasConceptScore W2056544932C2779263901 @default.
• W2056544932 hasConceptScore W2056544932C2779338263 @default.
• W2056544932 hasConceptScore W2056544932C2780653079 @default.
• W2056544932 hasConceptScore W2056544932C501593827 @default.
• W2056544932 hasConceptScore W2056544932C61511704 @default.
• W2056544932 hasConceptScore W2056544932C71924100 @default.
• W2056544932 hasConceptScore W2056544932C86803240 @default.
• W2056544932 hasConceptScore W2056544932C89423630 @default.

• next